WEIGHT LOSS
Eli Lilly investors spooked by weak Mounjaro sales, but it’s the obesity drug approval that will unlock its value
Eli Lilly investors spooked by weak Mounjaro sales, but it’s the obesity drug approval that will unlock its value
Quick Summary | Buy Mounjaro online
Strong demand has stoked high hopes for Eli Lilly’s Mounjaro, but insurance companies are slow to get on board, sparking fears among investors. Buy Mounjaro online
The trend contributed to disappointing fourth-quarter sales of the drug .Mounjaro tallied $279.2 million in sales, below the $319.3 million analysts were expecting, according to a Refinitiv poll.
That’s only up slightly from 45% in the third quarter.”We would have expected somewhat more of an uptick,” said SVB Securities analyst David Risinger in a research note Thursday.
